Requests that FDA consider a change in strength from RLD from 10 mg and 20 mg to 5 mg is suitable for submission as an ANDA
🏛 Food and Drug Administration (FDA)FDA-2026-P-4665
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.